James Noble - Net Worth and Insider Trading
James Noble Net Worth
The estimated net worth of James Noble is at least $6 Million dollars as of 2025-03-14. James Noble is the Director of GW Pharmaceuticals PLC and owns about 27,500 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $6 Million. James Noble is also the Director of Adaptimmune Therapeutics PLC and owns about 0 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $0. Details can be seen in James Noble's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Noble has not made any transactions after 2020-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Noble
James Noble Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Noble owns 3 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , GW Pharmaceuticals PLC (GWPH) , and Strata Skin Sciences Inc (SSKN) .
Click here to see the complete history of James Noble’s form 4 insider trades.
Insider Ownership Summary of James Noble
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2020-05-29 | director & Chief Executive Officer |
| GWPH | GW Pharmaceuticals PLC | 2020-06-04 | director |
| SSKN | Strata Skin Sciences Inc | 2011-12-08 | director |
James Noble Latest Holdings Summary
James Noble currently owns a total of 2 stocks. Among these stocks, James Noble owns 27,500 shares of GW Pharmaceuticals PLC (GWPH) as of May 24, 2019, with a value of $6 Million and a weighting of 100%. James Noble also owns 0 shares of Adaptimmune Therapeutics PLC (ADAP) as of May 29, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of James Noble
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GWPH | GW Pharmaceuticals PLC | 2019-05-24 | 27,500 | 218.96 | 6,021,400 |
| ADAP | Adaptimmune Therapeutics PLC | 2020-05-29 | 0 | 0.46 | 0 |
Holding Weightings of James Noble
James Noble Form 4 Trading Tracker
According to the SEC Form 4 filings, James Noble has made a total of 0 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years. The most-recent trade in GW Pharmaceuticals PLC is the sale of 82,596 shares on May 24, 2019, which brought James Noble around $1 Million.
According to the SEC Form 4 filings, James Noble has made a total of 1 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 500,000 shares on May 29, 2020, which brought James Noble around $5 Million.
Insider Trading History of James Noble
- 1
James Noble Trading Performance
James Noble Ownership Network
Ownership Network List of James Noble
Ownership Network Relation of James Noble
James Noble Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
James Noble is the director & Chief Executive Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, James Noble made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 158,756 shares made by Adrian Rawcliffe , a net sale of 60,150 shares made by Elliot Norry , and a net sale of 57,944 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 181,192 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 181,192 shares. During the past 18 months, 371,522 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 371,522 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
James Noble Mailing Address
Above is the net worth, insider trading, and ownership report for James Noble. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James Noble's mailing address is: Oxfordshire X0 Ox14 4rx.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
